Pharma Commercial Mock
IQVIA™
Connected Intelligence™
National Prescription Audit
Source: NPA Weekly · Refresh: 2026-10-30·Marten Veskimae
Brand-level trends · ZENVARA™

Weekly NPA dashboard · midwest

TRx (week)
410▼ 6.4%
vs WK29, 2026-10-30
NRx (week)
127▼ 4.5%
vs prior week
NBRx (week)
27▼ 6.9%
new-to-brand
Cumulative TRx
5,282
12-week window
📈TRx — plan vs actual
020240360508-1408-2809-1109-2510-0910-23
Plan Actual
📊NRx ⨉ NBRx trend
08-1408-2809-1109-2510-0910-23
NRx NBRx
🍩Channel mix
RETAIL33%MAIL58%LTC9%
🗺️Geography — variance vs plan
WestMidwestNortheastSoutheast
Variance vs plan — darker = worse. Northeast highlighted as primary deviation region.
Weekly detail · 12 weeks
Week EndingTRxNRxNBRxPlan TRxVar %Cum TRx
2026-08-1449214238545-9.7%492
2026-08-2145914136546-15.9%951
2026-08-2842312232547-22.7%1,374
2026-09-0448914235548-10.8%1,863
2026-09-1142812330548-21.9%2,291
2026-09-1843313232549-21.1%2,724
2026-09-2542613029549-22.4%3,150
2026-10-0242712429549-22.2%3,577
2026-10-0941612228549-24.2%3,993
2026-10-1644113828549-19.7%4,434
2026-10-2343813329550-20.4%4,872
2026-10-3041012727550-25.5%5,282
© 2026 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union and various other countries. NPA™, Xponent™ and Connected Intelligence™ are trademarks of IQVIA Inc. This view is a demo mock and is not affiliated with IQVIA.